View in EDS

Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.

Saved in:
Bibliographic Details
Title: Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Authors: Yu LR; College of Traditional Chinese Medicine, Chongqing Medical University, 401331 Chongqing, China., Han XZ; Department of Pharmacy, Chongqing General Hospital, Chongqing University, 400014 Chongqing, China., Tang YZ; Department of Pathology, Chongqing General Hospital, Chongqing University, 400014 Chongqing, China., Liu D; Department of Pharmacy, Chongqing General Hospital, Chongqing University, 400014 Chongqing, China., Luo XQ; College of Traditional Chinese Medicine, Chongqing Medical University, 401331 Chongqing, China., Qiu XW; Department of Pharmacy, Chongqing General Hospital, Chongqing University, 400014 Chongqing, China., Feng J; Department of Pharmacy, Chongqing General Hospital, Chongqing University, 400014 Chongqing, China., Yuan WX; Department of Pharmacy, Chongqing General Hospital, Chongqing University, 400014 Chongqing, China., Ding JY; Department of Pharmacy, Chongqing General Hospital, Chongqing University, 400014 Chongqing, China.
Source: Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2024 Apr 23; Vol. 29 (4), pp. 160.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: IMR Press Country of Publication: Singapore NLM ID: 101612996 Publication Model: Print Cited Medium: Internet ISSN: 2768-6698 (Electronic) Linking ISSN: 27686698 NLM ISO Abbreviation: Front Biosci (Landmark Ed) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2768-6698
DOI:10.31083/j.fbl2904160